Bayforest Capital’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-447
Closed -$144K 1113
2026
Q1
$144K Sell
447
-121
-21% -$36.1K 0.16% 234
2025
Q4
$147K Sell
568
-622
-52% -$142K 0.11% 377
2025
Q3
$270K Buy
1,190
+1,159
+3,739% +$238K 0.13% 322
2025
Q2
$6.48K Sell
31
-2,878
-99% -$554K ﹤0.01% 659
2025
Q1
$566K Buy
+2,909
New +$601K 0.25% 129

Other funds holding MSGS

Bayforest Capital's MSGS Position: Q2 2026 in Review

Bayforest Capital sold out of Madison Square Garden (MSGS) in Q2 2026, closing a stake of 447 shares — an estimated $144K sold.

Bayforest Capital first reported a position in MSGS in Q1 2025 and held it in 5 quarters. The position peaked at $566K in Q1 2025. 468 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • Bayforest Capital reported no remaining Madison Square Garden position as of Q2 2026 after selling out during the quarter.
  • Bayforest Capital sold 447 Madison Square Garden shares in Q2 2026, an estimated $144K.
  • Bayforest Capital first reported a position in Madison Square Garden in Q1 2025 and held it in 5 quarters.
  • Bayforest Capital's Madison Square Garden position peaked at $566K in Q1 2025.
  • 468 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.